EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors associated with long-term hypnotics use in depression

Adam Nygren, Pär Karlsson, Mikael Tiger, Philip Brenner, Karin Gembert, Zhiheng Zhang, Ying Qu, Jari Tiihonen, Heidi Taipale, Johan Reutfors

Journal of Affective Disorders · 2026

DOI: 10.1016/j.jad.2026.121415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Adam Nygren und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: adam.nygren@ki.se. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Depressive Disorder, Depression. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet, Janssen Pharmaceutica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypnotics are frequently used in depressed patients, but factors determining long-term use remain uncertain. Using national health registers, we included patients aged ≥18 years in Sweden 2007-2018 who filled a prescription for any drug indicated for sleep within three months after a diagnosis of depression in psychiatric specialist care. We excluded patients with dementia, bipolar or psychotic disorders, and those who had been Swedish residents for 180 defined daily doses of hypnotics across ≥3 prescription fills, including ≥1 fill in the second half of the year. Logistic regression was used to calculate unadjusted and adjusted odds ratios (ORs, aORs) with 95% confidence intervals (CI) to identify factors associated with long-term hypnotic use. We included 78,383 patients (mean age 39.4 years, 58.4% women). The most commonly initiated drug was a benzodiazepine-like hypnotic (Z-drug; n = 40,008; 51.0%), followed by the phenothiazine propiomazine (n = 30,940; 39.5%), melatonin (n = 6415; 8.2%), and benzodiazepine hypnotics (n = 1020; 1.3%). Overall, 23,476 of 78,383 patients (30.0%) met the criteria for long-term hypnotic use. In the adjusted model, older age was strongly associated with long-term hypnotic use (≥70 vs. 18-29 years: aOR 2.27, 95%CI 2.08-2.47), as was higher number of antidepressants in the past year (≥3 vs. 0: aOR 3.23, 95%CI 2.97-3.53). In this large cohort of patients with unipolar depression initiating hypnotic treatment, long-term use was more likely in older patients and those with multiple prior antidepressant trials, highlighting the need for careful clinical attention in these groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypnotics and SedativesDepressive DisorderDepressionHumansFemaleSwedenMaleAdultMiddle AgedRegistriesBenzodiazepinesAgedMelatoninYoung AdultAdolescent

Stichwörter der Autor:innen

BenzodiazepinesDepressionDrug utilisationHypnotic and sedativesMelatoninZ-drugs

Substanzen

Hypnotics and SedativesBenzodiazepinesMelatonin

Autor:innen und Institutionen

  • Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: adam.nygren@ki.se.
  • Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: par.karlsson@ki.se.
  • Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Sweden. Electronic address: mikael.tiger@ki.se.
  • Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care…
  • Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: karin.gembert@ki.se.
  • Johnson & Johnson Innovative Medicine, Raritan, NJ, United States. Electronic address: zzhan210@its.jnj.com.

Förderung

  • Karolinska Institutet
  • Janssen Pharmaceutica

Zitieren

APA

Nygren, A., Karlsson, P., Tiger, M., Brenner, P., Gembert, K., Zhang, Z., Qu, Y., Tiihonen, J., Taipale, H., & Reutfors, J. (2026). Factors associated with long-term hypnotics use in depression. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2026.121415

Vancouver

Nygren A, Karlsson P, Tiger M, Brenner P, Gembert K, Zhang Z, et al. Factors associated with long-term hypnotics use in depression. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2026.121415

BibTeX
@article{Nygren2026,
  author = {Nygren, Adam and Karlsson, Pär and Tiger, Mikael and Brenner, Philip and Gembert, Karin and Zhang, Zhiheng and Qu, Ying and Tiihonen, Jari and Taipale, Heidi and Reutfors, Johan},
  title = {Factors associated with long-term hypnotics use in depression},
  journal = {Journal of Affective Disorders},
  year = {2026},
  doi = {10.1016/j.jad.2026.121415}
}
Kostenlos starten →